Id |
Weergavenaam |
Ingangsdatum |
Type |
2.16.840.1.113883.2.4.3.36.10.100 |
CDA author |
|
cdaheaderlevel |
|
|
2.16.840.1.113883.2.4.3.36.10.216 |
Cancer pathology panel |
|
cdasectionlevel |
|
|
2.16.840.1.113883.2.4.3.36.10.31 |
Follow-up PA bevolkingsonderzoek borstkanker |
|
cdadocumentlevel |
|
|
2.16.840.1.113883.2.4.3.36.10.430 |
Version number protocol |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.36.10.592 |
Conclusion Pathology Entry (BK) |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.36.10.593 |
Oestrogeen receptor status |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.36.10.594 |
Progesteron receptor status |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.36.10.595 |
HER2 receptor status |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.36.10.596 |
Type tumor |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.36.10.597 |
Histologic grade Breast cancer Nottingham |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.36.10.598 |
UICC/AJCC TNM Staging and Grading Observation |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.36.10.599 |
TNM T-Observation |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.36.10.600 |
TNM N-Observation |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.36.10.601 |
TNM M-Observation |
|
cdaentrylevel |
|
|
2.16.840.1.113883.2.4.3.36.10.900005 |
Aanvang verrichting |
|
cdaheaderlevel |
|
|
2.16.840.1.113883.2.4.3.36.10.900014 |
Burger Service Nummer |
|
cdaheaderlevel |
|
|
2.16.840.1.113883.2.4.3.36.10.900035 |
Einde verrichting |
|
cdaheaderlevel |
|
|
2.16.840.1.113883.2.4.3.36.10.900800 |
CDA realmCode |
|
cdaheaderlevel |
|
|
2.16.840.1.113883.2.4.3.36.10.900801 |
CDA typeId |
|
cdaheaderlevel |
|
|
2.16.840.1.113883.2.4.3.36.10.900802 |
CDA id |
|
cdaheaderlevel |
|
|
2.16.840.1.113883.2.4.3.36.10.900803 |
CDA title |
|
cdaheaderlevel |
|
|
2.16.840.1.113883.2.4.3.36.10.900804 |
CDA effectiveTime |
|
cdaheaderlevel |
|
|
2.16.840.1.113883.2.4.3.36.10.900805 |
CDA confidentialityCode |
|
cdaheaderlevel |
|
|
2.16.840.1.113883.2.4.3.36.10.900806 |
CDA languageCode |
|
cdaheaderlevel |
|
|
2.16.840.1.113883.2.4.3.36.10.900807 |
CDA setId and versionNumber |
|
cdaheaderlevel |
|
|
2.16.840.1.113883.2.4.3.36.10.900809 |
CDA represented organization |
|
cdaheaderlevel |
|
|
2.16.840.1.113883.2.4.3.36.10.900810 |
CDA custodian |
|
cdaheaderlevel |
|
|
2.16.840.1.113883.2.4.3.36.10.900811 |
CDA informationRecipient |
|
cdaheaderlevel |
|
|
2.16.840.1.113883.2.4.3.36.10.900812 |
CDA authenticator |
|
cdaheaderlevel |
|
|
2.16.840.1.113883.2.4.3.36.10.900813 |
CDA legalAuthenticator |
|
cdaheaderlevel |
|
|
2.16.840.1.113883.2.4.3.36.10.900814 |
CDA relatedDocument |
|
cdaheaderlevel |
|
|
2.16.840.1.113883.2.4.3.36.10.900816 |
CDA documentationOf (PA-lab) |
|
cdaheaderlevel |
|
|
2.16.840.1.113883.2.4.3.36.10.900829 |
CDA Assigned Entity Identification |
|
cdaheaderlevel |
|
|
2.16.840.1.113883.2.4.3.36.10.900831 |
CDA recordTarget PA |
|
cdaheaderlevel |
|
|
rivmbk-template-1
|
Type CIS |
|
cdaentrylevel |
|
|
rivmbk-template-2
|
Type eenduidig benigne leasie(s) |
|
cdaentrylevel |
|
|
rivmbk-template-3
|
Type niet eenduidig benigne laesie(s) |
|
cdaentrylevel |
|
|
rivmbk-template-4
|
Gradering DCIS |
|
cdaentrylevel |
|
|
rivmbk-template-5
|
Type invasieve tumor (WHO) + overige |
|
cdaentrylevel |
|
|